Natasha Loda, Health Editor at The Economist, discusses the expanding uses of GLP-1 drugs beyond weight loss, emphasizing their potential in treating various health issues. Simon Rabinovich, US Economics Editor, analyzes the disconnect between strong economic data and public sentiment ahead of the election. Alice Su, Senior China Correspondent, shares harrowing stories of Chinese migrants risking everything for the American dream, illuminating their struggles and hopes along a treacherous journey. These conversations shed light on pressing health and societal issues.

Natasha Loda, Health editor for The Economist, discusses the promising GLP-1 drugs originally for diabetes that are now showing potential for obesity and various other diseases. Simon Rabinovich analyzes mixed economic indicators that may influence voter sentiment in the upcoming election. Meanwhile, Alice Su shares harrowing stories of Chinese migrants risking their lives to seek opportunities in America, highlighting the motivations and challenges of this perilous journey. Together, they unravel the intersecting narratives of health, economy, and migration.

Natasha Loda, Health editor for The Economist, dives into the transformative potential of GLP-1 drugs initially designed for diabetes, now being tested for broader health issues. Simon Rabinovich discusses the surprising disconnect between a booming US economy and the negative sentiment affecting voters as elections loom. Alice Su shares harrowing tales of Chinese migrants risking their lives through dangerous journeys to reach America, revealing the socio-political factors at play. Together, they explore pressing global health and migration issues intertwined with economic challenges.